Primary Care Enhanced Services

The NHS Lincolnshire Integrated Care Board plans to award a contract for the provision of Primary Care Enhanced Services, which includes a variety of health services such as Phlebotomy, Warfarin, and Specialised Drug Monitoring. Operating under the Health Care Services (Provider Selection Regime) Regulations 2023, this procurement relies on a direct award process applicable to the services category, specifically General Practitioner services, and is confined to the Lincolnshire region. The standstill period commenced on 10th September 2025, and interested parties have until 22nd September 2025 to make representations.

The contract is yet to be formally awarded, and Market Rasen Surgery is the intended supplier, with the contract expected to span from 1st April 2025 to 31st March 2026, valued at £147,994. This tender presents a robust opportunity for businesses, particularly those with experience in healthcare services and a focus on innovation, quality, and social value. Businesses well-versed in providing integrated healthcare services and those aiming to expand their portfolio in health inequalities reduction would find this an attractive prospect.

The direct award approach means competition is limited, offering an advantage to those already delivering similar services with proven capability and existing relationships within the healthcare system in Lincolnshire. Small and medium enterprises focusing on sustainable, community-driven healthcare solutions are well-suited to compete in this environment, particularly given the emphasis on collaboration and integration in healthcare provision.